Skip to main content

Table 2 Associations with mortality among 367 non-HCW COVID-19 inpatients in San Lazaro Hospital, January to October 2020

From: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines

Characteristics

All cases (n = 367)

Died (n = 60)

Discharged (n = 307)

P-value

Age (years)

 Mean (SD)

51 (18)

59 (20)

49 (17)

< 0.001

 Median (IQR)

53 (38–64)

65 (41–75)

51 (37–62)

 

Age group (years)

 0–10 years old

7 (1.9)

0

7 (100.0)

< 0.001

 11–20 years old

9 (2.4)

2 (22.2)

7 (77.8)

 

 21–40 years old

91 (24.8)

11 (12.1)

80 (87.9)

 

 41–60 years old

137 (37.3)

14 (10.2)

123 (89.8)

 

 61–80 years old

107 (29.2)

24 (22.4)

83 (77.6)

 

 80+ years old

16 (4.4)

9 (56.2)

7 (43.8)

 

Sex

 Female

158 (43.0)

17 (10.8)

141 (89.2)

0.015

 Male

209 (57.0)

43 (20.6)

166 (79.4)

 

Nationality

 Filipino

365 (99.5)

59 (16.6)

306 (83.8)

0.197

 Chinese

2 (0.5)

1 (50.0)

1 (50.0)

 

Exposure history

 International travel history within 14 days prior to admission

9 (2.5)

2 (22.2)

7 (77.8)

0.247

 Exposed to a confirmed case

11 (3.0)

0

11 (100.0)

 

 Risk of exposure in workplace

9 (2.5)

0

9 (100.0)

 

 No identified exposure

338 (92.0)

58 (17.2)

280 (82.8)

 

Reported symptoms

 Fever

227 (61.8)

39 (17.2)

188 (82.8)

0.583

 Cough

301 (82.0)

53 (17.6)

248 (82.4)

0.200

 Colds

91 (84.8)

9 (9.9)

82 (90.1)

0.071

 Difficulty of breathing

167 (45.5)

48 (28.7)

119 (71.3)

< 0.001

 Headache

18 (4.9)

2 (11.1)

16 (88.9)

0.749

 Malaise/fatigue

39 (10.6)

3 (7.7)

36 (92.3)

0.168

 Diarrhoea

29 (7.9)

1 (3.5)

28 (96.5)

0.050

 Anosmia

31 (8.4)

1 (3.2)

30 (96.7)

0.041

 Ageusia

27 (7.4)

1 (3.7)

26 (96.3)

0.065

 Loss of appetite

23 (6.3)

5 (21.7)

18 (78.3)

0.558

Co-morbidities

 Hypertension

140 (38.1)

22 (15.7)

118 (84.3)

0.796

 Diabetes

74 (20.2)

14 (18.9)

60 (81.1)

0.486

 Bronchial asthma

15 (4.1)

0

15 (100.0)

0.145

 HIV

6 (1.6)

4 (66.7)

2 (33.3)

0.008

 Cardiac disease

17 (4.6)

3 (17.6)

14 (82.3)

0.747

 Tuberculosis (any form)

37 (10.1)

10 (27.0)

27 (73.0)

0.097

 At least one underlying disease

205 (55.8)

36 (17.6)

169 (82.4)

0.480

Clinical status

 Asymptomatic

0

0

0

< 0.001

 Mild

73 (19.9)

1 (1.4)

71 (98.6)

 

 Moderate

106 (28.9)

0

104 (98.1)

 

 Severe

114 (31.1)

23 (20.2)

89 (77.4)

 

 Critical

63 (17.2)

36 (48.7)

38 (51.3)

 

Intubated

29 (7.9)

28 (96.5)

1 (3.5)

< 0.001

Duration between the onset of symptoms and admission

 Mean (SD)

8 (15)

5 (33)

8 (7)

0.229

 Median (IQR)

7 (5–10)

6 (4–9)

7 (5–10)

 

 0–14 days

322 (88.7)

53 (16.4)

269 (87.6)

0.047

 15–30 days

35 (9.6)

4 (11.4)

31 (88.6)

 

 > 30 days

6 (1.7)

3 (50.0)

3 (50.0)

 

Hospitalisation days

 Mean (SD)

12 (9)

7 (9)

13 (9)

< 0.001

 Median (IQR)

10 (7–15)

5 (1–10)

11 (8–16)

 

Other diagnoses

 Pneumonia

181 (49.3)

49 (27.1)

132 (72.9)

<0.001

 Upper respiratory tract infection

15 (4.1)

0

15 (100.0)

0.080

 Acute gastroenteritis

10 (2.7)

0

10 (100.0)

0.378

 Acute respiratory distress syndrome

48 (13.1)

33 (68.7)

15 (31.2)

<0.001

Ct-values distribution

N = 227

N = 36

N = 191

 

  11–20

3 (1.3)

1 (33.3)

2 (66.70)

0.178

  21–30

63 (27.7)

14 (22.2)

49 (77.8)

 

  31–40

159 (70.0)

20 (12.6)

139 (87.4)

 

  > 40

2 (0.9)

1 (50.0)

1 (50.0)